Clinical Evidence for N-Acetylcysteine in Psychiatric Treatment

This chapter examines clinical trial evidence for N-acetylcysteine (NAC) in treating psychiatric conditions, focusing on major depressive disorder and bipolar disorder. It discusses the relationship between inflammatory markers and treatment response, as well as promising outcomes from a pilot study on children with bipolar disorder.